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Abstract: Metagenomic next-generation sequencing is a powerful
method for pathogen detection that combines advanced genome sequencing technology with cutting-edge bioinformatics to analyze microbial
populations. Metagenomic next-generation sequencing has the potential
to identify uncommon, unculturable, and even previously unidentified
pathogens from a clinical isolate. Of particular interest to ophthalmology,
this robust data extraction can occur from very small volume clinical
samples. Here we discuss the opportunities and limitations of this
technique and their current and future application to ophthalmic diagnostics.
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Since its inception, mNGS has been used to improve the
identification of infectious microbes in many specimens currently
evaluated with cultures or targeted polymerase chain reaction
(PCR), for diseases such as culture-negative sepsis.1 This technique has also led to increased awareness of the microbial
diversity present in respiratory secretions, cerebrospinal fluids,
stool, blood, tissue, gastrointestinal infections, and ocular tissues1,2 and is also being studied to translate lung microbiomes to
develop a culture-independent treatment algorithm for respiratory
infections.3
Clinical metagenomics is beginning to play an important
role, not only in the identification of the normal flora of the human
eye, but also in evaluating pathogens that may be important in
ocular diseases. With the increasing advances of clinical metagenomics, there is likely to be a trend toward the use of mass
sequencing-based diagnostics in the identification of ocular
pathogens and ultimately in the treatment of ocular infections.

INTRODUCTION

C

linical metagenomics next-generation sequencing (mNGS)
is the comprehensive analysis of genetic samples (DNA or
RNA) to study microbial populations. Next-generation sequencing (NGS) technology, which is also referred to as deep sequencing, high-throughput sequencing, and massively parallel
sequencing, allows the simultaneous sequencing of all the genomic material present in small volume clinical samples. This datarich investigation relies on NGS technology, which represents a
revolution from previous Sanger sequencing methods in that
nucleic acid sequencing occurs by rapid, relatively cheap and
high-throughput methods, allowing millions of DNA/RNA segments to be simultaneously sequenced.1,2 NGS is inherently
unbiased and hypothesis-free, theoretically facilitating detection
of uncommon, unculturable, and even previously unidentified
pathogens from a clinical isolate. Importantly, the term metagenomics encompasses the analysis of entire populations of microorganisms.2 It draws on the large data provided by NGS, and highlevel bioinformatic analysis and interpretation of the data into
clinically useful information (Table 1).
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TRADITIONAL METHODS OF PATHOGEN
DETECTION
Culture is the current gold standard for pathogen detection4
and requires minimal prior knowledge of candidate microorganisms; however, it is time-consuming and limited to organisms that
can be grown on standard culture media. Other traditional methods for pathogen detection in ocular disease include PCR, a
technique that is well suited for herpes viruses which replicate
to high titers in the eye5; however, the sensitivity for organisms
like toxoplasmosis can be as low as 28% to 53% for aqueous
fluid.6,7 PCR reactions are specific to individual organisms and
therefore require prior knowledge of likely pathogens and sufficient ocular fluid to perform each reaction. Important drawbacks
of PCR include false positives due to multiple amplifications and
false negatives if primers mismatch to the organism’s genome.
Several techniques have been developed to overcome some of
these challenges, including nested or dual target PCR reactions in
which a second primer set improves specificity when low pathogen genomes necessitate additional amplification cycles. This
technique can improve sensitivity of toxoplasmosis detection to
nearly 100%.8 Additionally, multiplexed PCR reactions conserve
sample volumes and allow the analysis of multiple potential
pathogens in a single reaction.8
In addition to PCR, the Goldmann-Witmer coefficient has
been used to detect pathogen-specific intraocular antibodies. The
Goldmann-Witmer coefficient is helpful in establishing pathogenspecific antibody production within the ocular microenvironment
when the ratio of pathogen-specific antibodies to total antibodies
is higher in aqueous fluid compared to serum. Researchers have
found the usage of intraocular antibody in aqueous humor testing
to significantly contribute to the pathogen detection in infectious
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TABLE 1. Clinical Application of Next-generation Sequencing

1. Sample collection
a. Important considerations include sample storage and
processing if RNA will be assessed
2. Nucleic acid extraction
a. Methods specific to DNA or RNA
3. Library preparation
a. In the case of RNA specimens, the RNA must first be
reverse-transcribed to cDNA
b. This step often requires amplification which can introduce
bias toward more abundant amplicons
4. Sequencing
a. Shotgun (best for truly unbiased pathogen identification)
b. Targeted (cheaper, best for amplifying bacterial or fungal
species)
5. Bioinformatic analysis involves
a. data clean-up to remove adapter sequences and low-quality
reads
b. sequence alignment and removal of human genome
sequences
c. alignment of the remaining sequence reads to a pathogen
database
d. taxonomical classification
6. Interpretation of results, understanding that
b. rare or new pathogens may not be represented in sequence
databases
c. pathogens may be difficult to distinguish from related
organisms (ie, mycobacterial species) due to genetic
similarity
d. nonpathogens including normal flora or laboratory
contaminants can be inadvertently amplified
7. Ultimately the determination of pathogenicity must factor in the
clinical context.

uveitis, especially ocular toxoplasmosis.9 In addition to requiring
significant sample volume and prior knowledge of potential
pathogens, the Goldmann-Witmer technique requires several
weeks of ongoing infection to reach its highest sensitivity.9

ADVANCED PATHOGEN DETECTION WITH mNGS
Clinical mNGS is revolutionizing the detection of potential
human pathogens due to its ability to detect organisms that can be
missed by standard culture or targeted PCR techniques. Additionally, because all genomic material in a sample is sequenced,
this technique is inherently unbiased, allowing the identification
of organisms that may not have been suspected clinically and
discovery of previously unknown organisms. In addition to simple
pathogen detection, mNGS offers auxiliary genomic information
for evolutionary or epidemiologic tracing, strain identification,
and prediction of drug resistance.1
NGS can be done to identify both DNA and RNA sequences.
Although RNA sequencing requires special processing, DNA can
be deeply sequenced from fresh, frozen, or even paraformaldehyde-fixed tissues.1 Shotgun NGS refers to sequencing performed
simultaneously across random DNA fragments and is the most
unbiased approach, generally best for identifying most viruses,
some fungi, and previously unidentified pathogens.2 Targeted
amplicon sequencing can be utilized to amplify microbial rRNA
before sequencing.10,11 In this process, conserved microbial elements such as ribosomal RNA (rRNA) elements, 16S rRNA in the
case of bacterial species, and 28S rRNA or internal transcribed
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spacer for fungal species, are first amplified by generic primers,
then sequenced to identify the specific bacterial or fungal species.2 Importantly, this technique is less useful for viruses due to
their sequence variability, or eukaryote parasites due to the
similarity of their rRNA sequences to human. False positive
results can occur as a result of presequencing amplification of
contaminants. Finally, whole genome sequencing can be performed to quantify organisms, identify strain-specific mutations,
specific virulence or antibiotic resistance genes, or even characterize novel pathogens.1 This approach is best used for clinical
isolates or samples with low microbial diversity. Multiple
sequencing platforms are utilized and are beyond the scope of
this review; however, the interested reader is directed to an
excellent overview by Gu et al.1
An important consideration in the application of NGS to
metagenomic pathogen identification is that in most clinical
samples, the vast majority of nucleic acid present will actually
be human. Human nucleic acid can be removed before DNA/RNA
extraction by lysing the human cells with saponin or other
chemicals and degrading any DNA not protected by bacterial
or fungal cell walls or viral capsids.12 Alternatively, human
ribosomal and mitochondrial RNA can be significantly reduced
before sequencing by hybridization to human sequence-specific
probes or via Cas9 nuclease digestion.13 Both of these methods
result in some concurrent loss of pathogen nucleic acid. Finally,
targeted amplicon sequencing can be utilized as noted above to
enrich microbial rRNA.14
Quality control is highly critical at every step of this process
from sample acquisition and storage to bioinformatics algorithms
and these considerations were thoroughly reviewed by Gu et al.1
Practically speaking, careful attention to collection with rapid
cryostorage and advanced planning of sample processing and
analysis are critical to detect RNA viruses as RNA degrades
quickly and will not be detected by DNA sequencing methods
without an additional conversion to cDNA. Extensive bioinformatic processing of the data must be performed to filter out host
sequences and environmental contaminants and to correctly align
remaining potential pathogen sequences with genomic databases.1
Finally, the clinician must interpret the results of mNGS to
determine whether the organisms detected are likely to be pathogenic in their patient, which may require consultation with
infectious disease specialists.

UTILITY AND POTENTIAL IN UVEITIS
Diagnosis of intraocular infections can be complex, as
clinical presentations of specific pathogens can have significant
overlap. Traditionally, diagnosis was dependent upon diagnostic
testing like PCR and bacterial cultures. Unfortunately, culturebased assays have a relatively low sensitivity, ranging from 40%
to 70%15,16 and are time-consuming. Molecular diagnostic testing
like PCR is limited by its prespecified targets and can only
recognize a fraction of ocular pathogens. These techniques are
additionally limited by the relatively small sample volume that
can be safely obtained from the anterior chamber or the vitreous.
Given these limitations, it is not surprising that the causative agent
is unidentified in >50% of cases of presumed infectious uveitis.16,17 Metagenomics has the potential to radically increase the
diagnostic yield due to its unbiased nature and high throughput.
Additionally, it has the capability to detect bacteria, fungi, DNA
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and RNA viruses, and parasites from a <50 mL of intraocular
fluid.18,19
This technique has been used to identify causative organisms
in previously unidentified intraocular infections. Gonzales et al
used mNGS to identify rubella virus RNA from 6 patients with
recurrent or chronic hypertensive anterior or intermediate uveitis
which had previously tested negative for typical viral PCR [herpes
simplex virus 1 and 2 (HSV-1 and HSV-2), varicella-zoster virus,
and cytomegalovirus (CMV)],20 thus expanding the etiologic
spectrum for Fuch iridocyclitis to include rubella. Doan et al also
utilized the technique to identify organisms including CMV,
human herpes virus 6, HSV-2, human T lymphotropic virus 1,
Klebsiella pneumoniae, and Candida dubliensis in 8 of 36
archived vitreous samples that had previously tested negative
for HSV, varicella-zoster virus, CMV, and Toxoplasma gondii.19
Importantly, in this study, mNGS also correctly identified control
ocular specimens with HSV-1, C. neoformans, and T. gondii, and
did not detect anything beyond laboratory contaminants in control
noninfectious and noninflammatory samples, establishing a
framework for sensitivity and specificity of this novel technique
for use in ocular samples.
Remarkably, Doan et al demonstrated that ocular rubella
sequences isolated from 1 patient with bilateral chronic anterior
and intermediate uveitis aligned with a strain known to circulate
in the geographic region and time at which the patient had an
unexplained febrile illness as a child,18 illuminating the potential
for mNGS to facilitate epidemiologic investigations.
In a different approach, deep-sequencing performed after
16S amplification of ocular specimens from 21 patients with
presumed infectious endophthalmitis and 7 control patients
showed good concordance with bacterial and fungal culture,
and additionally revealed Streptococcus and Pseudomonas in
culture-negative samples.21 In a follow-up study, Lee et al used
whole genome sequencing to quantify pathogen genomes and
discovered that unlike endophthalmitis caused by other organisms, the burden of S. epidermidis organisms did not correlate
with severity of endophthalmitis.22
Lee et al also revealed for the first time, a presumably
nonpathogenic human anellovirus, torque teno virus (TTV), in
57.1% of the culture-positive specimens and 100% of the culturenegative specimens, but none of the control samples.21 TTV is
found at high titers in patients with multiple diseases, including
multiple sclerosis, systemic lupus erythematosus, fever of
unknown origin, rheumatic diseases, and hepatitis, and has been
associated with increased rates of posttransplant infection and
transplant rejection,23 suggesting that TTV may be associated
with altered immune responses and/or may confer addition pathogenicity to other disease states. In support of this, Lee et al21 also
discovered that the presence of TTV conferred a 5-fold risk for
second vitrectomy. In another study, Naik et al also found a
significant association of TTV and its variant TLMV in patients
with endophthalmitis compared to control patients undergoing
vitrectomy for noninfectious pathology; however, they also found
that TTV/TLMV was present significantly more often in eyes that
had more injections or procedures.24 Although it is possible that
TTV was introduced iatrogenically, in light of the aforementioned
data, these results are more suggestive that the presence of TTV
may be a biomarker for more severe ocular disease, a finding
additionally suggested by the high levels of TTV in the severe
condition, seasonal hyperacute panuveitis.25 Importantly,
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although the ability of mNGS to detect novel organisms like
TTV provides a unique opportunity to research potential biomarkers of disease severity, it can also make determination of
disease etiology challenging for the practicing physician.
An additional advantage of mNGS is the ability to simultaneously assess for mutations in the genomic material identified.
This can be used to detect mutations that may confer treatment
resistance, as Doan et al found in some samples in which CMV
sequences were isolated.19 Of the 7 samples analyzed, 3 demonstrated mutations in the UL97 gene coding for phosphotransferase
that confer resistance to ganciclovir and valganciclovir. Similarly,
Kirstahler et al identified mutations conferring antibiotic resistance in isolates from patients with postoperative endophthalmitis
through metagenomics analysis.26
The utility of the sequence data obtained through mNGS is
not limited to infectious etiologies. Gonzales et al detected 2
patients with uveitic masquerade syndromes through mNGS on
vitreous and aqueous specimens, confirmed by ancillary testing,
including flow cytometry, Ig-kappa gene rearrangement, and
cytopathology.27 The first patient showed the presence of both
Epstein-Barr virus and human herpes virus 8, both of which cause
primary effusion lymphoma.27 The second patient was negative
for infectious agents; however, analysis of the host sequence
revealed the S243N mutation in MYD88, which has been associated with the activated B-cell subtype of diffuse large B cell
lymphoma.27 Because this mutation is less common than the
L265P mutation traditionally associated with primary vitreoretinal lymphoma,27 it may have been missed by typical PCR analysis
of the aqueous specimen, suggesting that mNGS is also more
sensitive for detecting noninfectious ocular disease.

UTILITY AND POTENTIAL IN CONJUNCTIVITIS,
CORNEAL TRANSPLANTS, OR OTHER DISEASES OF
THE OCULAR SURFACE
Metagenomics also has the potential to change the way we
analyze and treat diseases of the ocular surface, including diseases
of the cornea and conjunctiva. The organisms populating the
ocular surface have previously been identified using culture-based
techniques28; however, as in the case of culture-negative endophthalmitis, this methodology has the potential to miss many microflorae that do not successfully grow in the lab.
With the application of expanded molecular sequencing,
such as mNGS, researchers suggest that the normal microbiota
of the healthy ocular surface is more diverse than previously
thought,29–31 although still far less diverse than skin, oral, and
intestinal microbiomes.18,32 In addition, the ocular microbiome
hosts relatively few bacterial taxa that are relatively stable across
individuals, and this may point to a role for the microbiome in
immune modulation.32,33,34
Metagenomics RNA sequencing has been used to help
identify potential causative pathogens in infectious conjunctivitis
and keratitis. Lalitha et al35 (2020) extracted RNA from inferior
fornix conjunctival swabs; of the 14 eyes sampled, 12 (86%) were
positive for human pathogens, with adenovirus being the most
common etiology followed by a fungal organism, Vittaforma
Corneae. Seitzman et al36 also utilized metagenomic sequencing
of aqueous fluid to identify a case of Capnocytophaga keratitis
that could not be cultured. Thus, mNGS may also be used for the
identification of causative organisms that could help target
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appropriate antibiotic use and decrease the inappropriate use
of antibiotics in the case of viral, fungal, or noninfectious
conjunctivitis.
Metagenomics may also be applicable for screening for
microorganisms present in the storage media of human donor
cornea tissue. The standard commercially available corneal storage media contain penicillin and streptomycin for antibacterial
coverage and amphotericin B for antifungal coverage. Parekh et al
(2019) extracted genetic material from multiple bacterial and
fungal organisms such as Pseudomonas spp, Comamonas spp, and
Malassezia sp which were present in both the room temperature
and hypothermic storage media.37 Importantly, additional methods to confirm the presence of live organisms were not performed,
highlighting the fact that mNGS cannot confirm the presence of
live microorganisms, nor their eradication by antimicrobials in the
organ culture medium.37

practice requires an awareness that these techniques have the
potential to amplify irrelevant genomic material, resulting in data
that can complicate or confuse clinical decision making.
Future developments that will make this technology more
clinically applicable include streamlined and automated bioinformatics data processing, improved data storage, and reduced
sequencing costs. Additionally, the ability to identify live organisms with certainty will require optimized collection and sample
storage methods to preserve RNA integrity and expanded use of
RNA sequencing methods.
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